Cargando…
Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy
BACKGROUND: Total body irradiation (TBI) is often a component of the conditioning regimen prior to hematopoietic stem cell transplantation in patients with hematological malignancies. However, total marrow irradiation (TMI) could be an alternative method for reducing radiation therapy-associated tox...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356893/ https://www.ncbi.nlm.nih.gov/pubmed/36607428 http://dx.doi.org/10.1007/s00432-022-04565-2 |
_version_ | 1785075376607723520 |
---|---|
author | Köksal, Mümtaz Kersting, Laura Schoroth, Felix Garbe, Stephan Koch, David Scafa, Davide Sarria, Gustavo R. Leitzen, Christina Heine, Annkristin Holderried, Tobias Brossart, Peter Zoga, Eleni Attenberger, Ulrike Schmeel, Leonard C. |
author_facet | Köksal, Mümtaz Kersting, Laura Schoroth, Felix Garbe, Stephan Koch, David Scafa, Davide Sarria, Gustavo R. Leitzen, Christina Heine, Annkristin Holderried, Tobias Brossart, Peter Zoga, Eleni Attenberger, Ulrike Schmeel, Leonard C. |
author_sort | Köksal, Mümtaz |
collection | PubMed |
description | BACKGROUND: Total body irradiation (TBI) is often a component of the conditioning regimen prior to hematopoietic stem cell transplantation in patients with hematological malignancies. However, total marrow irradiation (TMI) could be an alternative method for reducing radiation therapy-associated toxicity, as it specifically targets the skeleton and thus could better protect organs at risk. Here, we compared dosimetric changes in irradiation received by the target volume and organs at risk between TBI and TMI plans. MATERIALS AND METHODS: Theoretical TMI plans were calculated for 35 patients with various hematological malignancies who had already received TBI in our clinic. We then statistically compared irradiation doses between the new TMI plans and existing TBI plans. We examined whether TMI provides greater protection of organs at risk while maintaining the prescribed dose in the targeted skeletal area. We also compared beam-on times between TBI and TMI. RESULTS: TMI planning achieved significant reductions in the mean, minimum, and maximum irradiation doses in the lungs, kidneys, liver, spleen, and body (i.e., remaining tissue except organs and skeleton). In particular, the mean dose was reduced by 49% in the liver and spleen and by 55–59% in the kidneys. Moreover, TMI planning reduced the corpus beam-on time by an average of 217 s. CONCLUSION: TMI planning achieved significant dose reduction in organs at risk while still achieving the prescribed dose in the target volume. Additionally, TMI planning reduced the beam-on time for corpus plans despite a high modulation factor. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-022-04565-2. |
format | Online Article Text |
id | pubmed-10356893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-103568932023-07-21 Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy Köksal, Mümtaz Kersting, Laura Schoroth, Felix Garbe, Stephan Koch, David Scafa, Davide Sarria, Gustavo R. Leitzen, Christina Heine, Annkristin Holderried, Tobias Brossart, Peter Zoga, Eleni Attenberger, Ulrike Schmeel, Leonard C. J Cancer Res Clin Oncol Research BACKGROUND: Total body irradiation (TBI) is often a component of the conditioning regimen prior to hematopoietic stem cell transplantation in patients with hematological malignancies. However, total marrow irradiation (TMI) could be an alternative method for reducing radiation therapy-associated toxicity, as it specifically targets the skeleton and thus could better protect organs at risk. Here, we compared dosimetric changes in irradiation received by the target volume and organs at risk between TBI and TMI plans. MATERIALS AND METHODS: Theoretical TMI plans were calculated for 35 patients with various hematological malignancies who had already received TBI in our clinic. We then statistically compared irradiation doses between the new TMI plans and existing TBI plans. We examined whether TMI provides greater protection of organs at risk while maintaining the prescribed dose in the targeted skeletal area. We also compared beam-on times between TBI and TMI. RESULTS: TMI planning achieved significant reductions in the mean, minimum, and maximum irradiation doses in the lungs, kidneys, liver, spleen, and body (i.e., remaining tissue except organs and skeleton). In particular, the mean dose was reduced by 49% in the liver and spleen and by 55–59% in the kidneys. Moreover, TMI planning reduced the corpus beam-on time by an average of 217 s. CONCLUSION: TMI planning achieved significant dose reduction in organs at risk while still achieving the prescribed dose in the target volume. Additionally, TMI planning reduced the beam-on time for corpus plans despite a high modulation factor. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-022-04565-2. Springer Berlin Heidelberg 2023-01-06 2023 /pmc/articles/PMC10356893/ /pubmed/36607428 http://dx.doi.org/10.1007/s00432-022-04565-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Köksal, Mümtaz Kersting, Laura Schoroth, Felix Garbe, Stephan Koch, David Scafa, Davide Sarria, Gustavo R. Leitzen, Christina Heine, Annkristin Holderried, Tobias Brossart, Peter Zoga, Eleni Attenberger, Ulrike Schmeel, Leonard C. Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy |
title | Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy |
title_full | Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy |
title_fullStr | Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy |
title_full_unstemmed | Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy |
title_short | Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy |
title_sort | total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356893/ https://www.ncbi.nlm.nih.gov/pubmed/36607428 http://dx.doi.org/10.1007/s00432-022-04565-2 |
work_keys_str_mv | AT koksalmumtaz totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT kerstinglaura totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT schorothfelix totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT garbestephan totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT kochdavid totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT scafadavide totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT sarriagustavor totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT leitzenchristina totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT heineannkristin totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT holderriedtobias totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT brossartpeter totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT zogaeleni totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT attenbergerulrike totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy AT schmeelleonardc totalmarrowirradiationversustotalbodyirradiationusingintensitymodulatedhelicaltomotherapy |